SBFMW
Sunshine Biopharma Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CA
$0.05
+74.19%Next report
Analyst consensus
- Next report date
- Nov 10, 2026
- EPS estimate
- -$0.17
- Revenue estimate
- $9.6M
Latest reported
- Last report date
- Aug 13, 2026
- EPS actual
- -$1.05
- EPS estimate
- -$1.20
- Revenue actual
- -$9.4M
- Revenue estimate
- $8.7M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 1
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -72.9%
- Revenue beats (12Q)
- 0
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 13, 2026 | -$1.20 | -$1.05 | Beat 12.50% | -$9.4M |
| May 13, 2026 | -$0.25 | -$0.25 | In line | $8.1M |
| Nov 13, 2025 | -$0.13 | -$0.19 | Miss -46.15% | $9.4M |
| Aug 12, 2025 | -$0.11 | -$0.39 | Miss -258.05% | $9.4M |
| May 15, 2025 | — | -$1.68 | — | $8.9M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026